Syed IB, Nannapaneni M. Related Substances Method Development and Validation of Axitinib, Zanubrutinib and Upadacitinib Using RP-HPLC and its Degradation Products were Characterized by Using LC-MS/MS. ijpi [Internet]. 16Dec.2022 [cited 29Mar.2023];13(1):113-21. Available from: https://jpionline.org/index.php/ijpi/article/view/1696